Lataa...
An Observational Study of Bevacizumab-Induced Hypertension as a Clinical Biomarker of Antitumor Activity
BACKGROUND. Hypertension is a common toxicity of bevacizumab, but the frequency of assessment of blood pressure and standardized grading remain to be defined. This study aimed to describe the incidence of bevacizumab-induced hypertension and factors associated with its development, then to retrospec...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AlphaMed Press
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228164/ https://ncbi.nlm.nih.gov/pubmed/21807768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|